NASDAQ: VTVTVtv Therapeutics Inc Stock Ownership - Who owns Vtv Therapeutics?
Insider buying vs selling
Have Vtv Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when VTVT insiders and whales buy or sell their stock.
VTVT Shareholders
What type of owners hold Vtv Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Ronald O. Perelman | 984.31% | 38,919,878 | $1.00B | Insider |
| Tahnoon Bin Zayed S. Alnahyan | 262.68% | 10,386,274 | $267.13M | Insider |
| G42 Investments Ai Holdings Rsc Ltd | 262.68% | 10,386,274 | $267.13M | Insider |
| Srinivas Akkaraju | 7.91% | 312,784 | $8.04M | Insider |
| Samsara Biocapital GP LLC | 5.23% | 206,784 | $5.32M | Insider |
| Baker Bros Advisors LP | 3.44% | 135,946 | $3.50M | Insider |
| Paul G. Savas | 2.32% | 91,781 | $2.36M | Insider |
| John A. Fry | 1.54% | 61,000 | $1.57M | Insider |
| Rich S. Nelson | 1.52% | 60,000 | $1.54M | Insider |
| Jeffrey B. Kindler | 0.89% | 35,000 | $900.20k | Insider |
VTVT vs Biotech Stocks
Vtv Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.